Related Experiment Video
Updated: Jan 23, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Doxorubicin-induced testicular damage is related to PARP-1 signaling molecules in mice
Nazli Ece Gungor-Ordueri1, Nilay Kuscu2, Arda Tasatargil3
1Department of Histology and Embryology, Medical Faculty of Biruni University, Campus, Istanbul, Turkey.
Background:
Doxorubicin (DOX), is a chemotherapeutic agent, which evokes oxidative stress and cell apoptosis in testicular tissue. It is known that the activation of the nuclear enzyme poly (ADP-ribose) polymerase (PARP), leading to apoptosis induced by DOX. The aim of the present study is to investigate whether PARP pathway has a role in DOX-induced testicular damage and infertility utilizing pharmacological PARP-1 inhibitor, PJ34, and PARP-1 knockout mice model.
Methods:
Firstly, we assessed the activation of PARP pathway after DOX-induction at various hours by immunohistochemistry and western blot analysis. Secondly, we evaluated the role of PARP pathway in DOX-induced testicular damage, sperm motility, and fertility with pharmacological inhibition of PARP by using PJ34. Finally, we aimed to correlate a functional relationship between PARP-1 and DOX using PARP-1 knockout mice in DOX-induced testicular damage. Doxorubicin levels in plasma and testis tissue were also assessed.
Results:
In DOX-induced group; PARP-1, PAR and apoptotic pathway protein expressions, increased significantly. In DOX + PJ34 group; PAR, cytochrome c, and AIF levels decreased significantly. Testicular weights, sperm motility, and mean the number of pups per litter decreased in DOX-induced group after 28 days, however they were similar to the control group in DOX-PJ34 group. In PARP-1 KO group, seminiferous tubule morphology was impaired significantly after 28 days of DOX-administration.
Conclusions:
Our study indicates that DOX-induced testicular damage may be related to over-activation of PARP-1. PJ34 application was effective in preventing severe testicular damage caused by DOX-injection and may be considered for fertility protection against DOX-induced testicular damage.
Insights
Doxorubicin causes testicular damage via PARP-1 activation. Inhibiting PARP-1 with PJ34 protected sperm motility and fertility, suggesting a therapeutic role for fertility preservation.
Area of Science:
- Reproductive toxicology
- Molecular biology
- Biochemistry
Background:
- Doxorubicin (DOX) chemotherapy induces testicular damage and apoptosis through oxidative stress.
- Poly (ADP-ribose) polymerase (PARP) activation is a key mediator of DOX-induced apoptosis.
- The role of PARP in DOX-induced testicular dysfunction requires further investigation.
Purpose of the Study:
- To investigate the role of the PARP pathway in doxorubicin-induced testicular damage and infertility.
- To evaluate the protective effects of the PARP-1 inhibitor PJ34 against DOX-induced testicular toxicity.
- To confirm the functional link between PARP-1 and DOX using a PARP-1 knockout mouse model.
Main Methods:
- Assessed PARP pathway activation post-DOX induction using immunohistochemistry and western blot.
- Evaluated the impact of PJ34 on DOX-induced testicular damage, sperm motility, and fertility.
- Utilized PARP-1 knockout mice to establish a direct correlation between PARP-1 and DOX toxicity.
- Quantified doxorubicin levels in plasma and testicular tissue.
Main Results:
- DOX treatment significantly increased PARP-1, PAR, and apoptotic protein expression.
- PJ34 administration reduced PAR, cytochrome c, and AIF levels, mitigating DOX-induced damage.
- DOX-induced decreases in testicular weight, sperm motility, and fertility were reversed by PJ34.
- PARP-1 knockout mice exhibited significant seminiferous tubule impairment after DOX administration.
Conclusions:
- Over-activation of PARP-1 is implicated in doxorubicin-induced testicular damage.
- Pharmacological inhibition of PARP-1 with PJ34 effectively prevents severe testicular damage.
- PJ34 shows potential for fertility protection in patients undergoing doxorubicin chemotherapy.
Related Concept Videos
Types of Signaling Molecules
Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule
Bacterial Signaling
What is Cell Signaling?
Paracrine Signaling
Synaptic Signaling

